샘플 요청 목록

 카트 문의
시장보고서
상품코드
1655343

세계의 말라리아 진단 시장

Malaria Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 162 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말라리아 진단 세계 시장은 2030년까지 13억 달러에 달할 전망

2024년에 9억 170만 달러로 추정되는 말라리아 진단 세계 시장은 분석기간인 2024-2030년에 CAGR 5.6%로 성장하여 2030년에는 13억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 신속 진단 검사는 CAGR 5.7%를 기록하며 분석기간 종료시에는 6억 8,590만 달러에 달할 것으로 예측됩니다. 현미경 진단 부문의 성장률은 분석기간 동안 CAGR 4.9%로 추정됩니다.

미국 시장은 2억 3,330만 달러로 추정, 중국은 CAGR 8.6%로 성장 예측

미국의 말라리아 진단 시장은 2024년에는 2억 3,330만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 2억 9,000만 달러의 시장 규모에 달할 것으로 예측되며, 분석기간인 2024-2030년 CAGR은 8.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석기간 동안 CAGR은 각각 3.3%와 4.5%로 예측됩니다. 유럽에서는 독일이 CAGR 4.2%로 성장할 것으로 예측됩니다.

세계 말라리아 진단 시장 - 주요 동향 및 촉진요인 정리

이 풍토병과의 싸움에서 말라리아 진단은 어떻게 진화하고 있는가?

말라리아 진단은 특히 사하라 사막 이남의 아프리카 및 동남아시아 지역에서 가장 널리 퍼져 있는 기생충성 질환과의 싸움에서 매우 중요합니다. 말라리아를 효과적으로 치료하고 심각한 합병증과 사망을 예방하기 위해서는 말라리아를 정확하고 조기에 발견하는 것이 필수적입니다. 현미경 검사나 신속 진단 검사(RDT)와 같은 전통적인 진단 방법은 오랫동안 말라리아 진단의 표준이었습니다. 그러나 진단 기술의 발전으로 이러한 검사의 정확성, 속도, 접근성이 향상되고 있습니다. 중합효소 연쇄 반응(PCR) 검사와 같은 새로운 분자진단 도구는 민감도가 향상되어 기존 방법으로는 놓치기 쉬운 낮은 수준의 기생충을 검출할 수 있습니다. 진단 기술의 발전은 말라리아를 퇴치하고 환자의 예후를 개선하기 위한 전 세계의 노력을 지속하는 데 필수적입니다.

말라리아 진단을 변화시키고 있는 기술 혁신은 무엇일까?

기술 혁신은 말라리아 진단의 정확성과 접근성을 향상시키는 데 큰 진전을 이루었습니다. 가장 주목할 만한 개발 중 하나는 휴대용 분자 검사 장비의 도입으로, 이를 통해 원격지나 자원이 제한된 환경에서도 높은 정확도의 검출이 가능해졌다는 점입니다. 기술을 이용한 이러한 검사 장비는 대규모 검사 인프라를 필요로 하지 않고도 신속하게 결과를 얻을 수 있습니다. 또한, 디지털 현미경의 발전으로 기생충의 자동 검출이 가능해져 인적 오류를 줄이고 진단 워크플로우의 효율성이 향상되었으며, AI와 머신러닝을 진단에 통합하여 검사 결과의 해석을 더욱 개선하여 임상의가 말라리아 치료와 관련하여 더 빠르고 신뢰할 수 있는 판단을 내릴 수 있도록 돕고 있습니다. 할 수 있게 되었습니다.

자원이 부족한 지역에서 말라리아 진단이 직면한 과제는 무엇인가?

말라리아 진단의 발전에도 불구하고, 자원이 부족한 지역에서 이러한 도구를 배포하는 데에는 몇 가지 문제가 있습니다. 가장 큰 문제 중 하나는 첨단 진단 방법의 비용과 복잡성으로, 말라리아가 가장 널리 퍼져 있는 오지에서의 활용을 제한할 수 있다는 점입니다. 현미경 검사나 RDT와 같은 전통적인 방법은 비용 효율적이지만 숙련된 인력이 필요하며, 여전히 낮은 수준의 감염을 놓칠 가능성이 있습니다. 또 다른 과제는 진단 재료의 공급망을 유지하여 발병 시 접근하기 어려운 지역에서도 검사를 받을 수 있도록 하는 것입니다. 또한, 지역마다 진단의 질이 다양하고 훈련과 장비가 일정하지 않아 신뢰할 수 있는 말라리아 진단에 대한 보편적 접근을 달성하기 위한 노력을 방해하고 있습니다. 이러한 장벽을 해결하는 것은 말라리아 관리를 개선하고 궁극적으로 발병 지역의 질병 부담을 줄이기 위해 매우 중요합니다.

말라리아 진단 시장의 성장은 몇 가지 요인에 의해 발생합니다.

말라리아 진단 시장의 성장은 말라리아 발병 지역의 말라리아 유병률 증가, 진단 기술의 발전, 말라리아 퇴치를 위한 전 세계의 노력 등 여러 요인에 의해 주도되고 있습니다. 휴대용 분자진단 및 AI 기반 도구와 같은 기술 혁신은 의료 인프라가 부족한 지역에서도 정확하고 시기적절한 진단에 대한 접근성을 높여주고 있습니다. 말라리아 퇴치를 위한 정부 및 비정부기구의 자금 지원 증가도 개선된 진단 방법의 채택을 가속화하고 있습니다. 또한, 말라리아의 중증화 및 사망을 예방하기 위해서는 조기 발견이 중요하다는 인식이 높아지면서 보다 신뢰할 수 있고 효율적인 검사 솔루션에 대한 수요가 증가하고 있습니다. 이러한 요인과 지속적인 연구 개발 노력이 결합되어 말라리아 진단 시장의 지속적인 성장이 예상됩니다.

부문

부문(신속진단 검사, 현미경 진단, 분자진단)

조사 대상 기업 예시(16개사)

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.03.14

Global Malaria Diagnostics Market to Reach US$1.3 Billion by 2030

The global market for Malaria Diagnostics estimated at US$901.7 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the analysis period. Growth in the Microscopic Diagnostics segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$233.3 Million While China is Forecast to Grow at 8.6% CAGR

The Malaria Diagnostics market in the U.S. is estimated at US$233.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$290.0 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Malaria Diagnostics Market - Key Trends & Drivers Summarized

How Are Malaria Diagnostics Evolving in the Fight Against This Endemic Disease?

Malaria diagnostics are crucial in the global fight against one of the most prevalent parasitic diseases, particularly in regions like sub-Saharan Africa and Southeast Asia. Accurate and early detection of malaria is essential to effectively treating the disease and preventing severe complications or death. Traditional diagnostic methods like microscopy and rapid diagnostic tests (RDTs) have long been the gold standard in malaria diagnosis. However, advances in diagnostic technologies are improving the accuracy, speed, and accessibility of these tests. New molecular diagnostic tools, such as polymerase chain reaction (PCR) testing, have enhanced sensitivity and can detect low parasite levels that are often missed by conventional methods. The evolution of diagnostic techniques is vital in the ongoing global efforts to eliminate malaria and improve patient outcomes.

What Technological Innovations Are Transforming Malaria Diagnostics?

Technological innovations are driving significant advancements in malaria diagnostics, improving their accuracy and accessibility. One of the most notable developments is the introduction of portable molecular testing devices, which allow for highly accurate detection in remote or resource-limited settings. These devices, which use techniques like loop-mediated isothermal amplification (LAMP), can provide results quickly without requiring extensive laboratory infrastructure. Additionally, advancements in digital microscopy have enabled automated parasite detection, reducing human error and increasing the efficiency of diagnostic workflows. The integration of AI and machine learning in diagnostics has further improved the interpretation of test results, helping clinicians make faster and more reliable decisions regarding malaria treatment.

What Are the Challenges Facing Malaria Diagnostics in Resource-Limited Areas?

Despite the progress in malaria diagnostics, there are several challenges in deploying these tools in resource-limited areas. One major issue is the cost and complexity of advanced diagnostic methods, which can limit their availability in remote regions where malaria is most prevalent. Traditional methods like microscopy and RDTs, while cost-effective, require skilled personnel and can still miss low-level infections. Another challenge is maintaining the supply chain for diagnostic materials and ensuring that tests are available in hard-to-reach areas during outbreaks. Additionally, the variability in diagnostic quality across regions, driven by inconsistent training and equipment, hinders efforts to achieve universal access to reliable malaria diagnostics. Addressing these barriers is critical for improving malaria management and ultimately reducing the disease burden in endemic areas.

Growth in the Malaria Diagnostics Market Is Driven by Several Factors

The growth in the malaria diagnostics market is driven by several factors, including the increasing prevalence of malaria in endemic regions, advancements in diagnostic technologies, and global efforts toward malaria elimination. Technological innovations such as portable molecular diagnostics and AI-driven tools are expanding access to accurate and timely diagnostics in areas with limited healthcare infrastructure. The rise in funding from governmental and non-governmental organizations aimed at combating malaria is also accelerating the adoption of improved diagnostic methods. Furthermore, the growing awareness of the importance of early detection in preventing severe malaria cases and fatalities is pushing demand for more reliable and efficient testing solutions. These factors, combined with ongoing R&D efforts, are expected to drive continued growth in the malaria diagnostics market.

SCOPE OF STUDY:

The report analyzes the Malaria Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Rapid Diagnostic Tests, Microscopic Diagnostics, Molecular Diagnostics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Malaria Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Malaria Drives Growth in Malaria Diagnostics Market
    • Technological Advancements in Rapid Diagnostic Tests Propel Adoption in Malaria-endemic Regions
    • Increased Focus on Early Detection Strengthens Business Case for Advanced Diagnostic Solutions
    • Emergence of Point-of-care Diagnostics Spurs Growth in Remote and Low-resource Settings
    • Rising Availability of Multiplex Diagnostic Platforms Propels Adoption of Comprehensive Testing
    • Increasing Global Health Initiatives to Combat Malaria Expand Market for Diagnostic Tools
    • Advancements in Molecular Diagnostics Strengthen Business Case for Accurate Malaria Detection
    • Rising Need for Accurate Surveillance Tools Accelerates Demand for Innovative Diagnostics
    • Growing Focus on Precision Medicine Generates Demand for Genotype-specific Malaria Diagnostics
    • Improved Diagnostic Technologies Propel Growth in Drug Resistance Testing for Malaria
    • Increasing Prevalence of Multi-drug-resistant Malaria Strains Drives Need for Advanced Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Malaria Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Rapid Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Microscopic Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • JAPAN
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CHINA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • EUROPE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • FRANCE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • GERMANY
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • INDIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AFRICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제